Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy

Схожие документы

• A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
  по: Lorson, Christian L., et al.
  Опубликовано: (1999)
• Intraperitoneal delivery of a novel drug‐like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy
  по: Osman, E. Y., et al.
  Опубликовано: (2019)
• Small Molecules in Development for the Treatment of Spinal Muscular Atrophy
  по: Calder, Alyssa N., et al.
  Опубликовано: (2016)
• Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy
  по: Rietz, Anne, et al.
  Опубликовано: (2017)
• Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds
  по: Cherry, Jonathan J, et al.
  Опубликовано: (2013)